anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Larimar Therapeutics · conference-presentation

Larimar Therapeutics | Results Presentation Deck | 15 slides

15 pages · 4 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

Larimar Therapeutics | Results Presentation Deck | 15 slides

Larimar Therapeutics · 2022-11
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 10 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 7 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Agitate 2 slides 100% 2/2 slides 100% 2/2 slides · 7 hits
— 0/2 slides
— 0/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides Solution 6 slides 100% 6/6 slides 100% 6/6 slides · 27 hits
— 0/6 slides
— 0/6 slides
— 0/6 slides
100% 6/6 slides 100% 6/6 slides Action 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

15
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a comparison of protein structures to explain the mechanism of action for the therapeutic candidate.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
04
The slide uses a target icon to visually represent the 'objective' concept.establish_context
Open slide detailBeat · AgitateLoop · Cost Of Inaction
05
establish_context
Open slide detailBeat · AgitateLoop · Cost Of Inaction
06
The slide uses a timeline-style visualization to represent dosing schedules for different cohorts.present_framework
Open slide detailLoop · Hypothesis Test
07
Slide outlines the clinical trial methodology for safety and PK analysis.present_framework
Open slide detailLoop · Hypothesis Test
08
The table compares Placebo against four dosage levels of CTI-1601 (25mg, 50mg, 75mg, 100mg).analyze_data
Open slide detailLoop · Hypothesis Test
09
The table displays patient counts and percentages for various adverse events, including injection-site reactions.analyze_data
Open slide detailBeat · SolutionLoop · Hypothesis Test
10
SAD = Single Ascending Dose study.analyze_data
Open slide detailBeat · SolutionLoop · Hypothesis Test
11
MAD = Multiple Ascending Dose; SAD = Single Ascending Dose.analyze_data
Open slide detailBeat · SolutionLoop · Hypothesis Test
12
The table details patient counts and percentages for various adverse events, including injection-site reactions.analyze_data
Open slide detailBeat · SolutionLoop · Hypothesis Test
13
MAD = multiple ascending dose. Data points are estimated based on the three line charts provided.analyze_data
Open slide detailBeat · SolutionLoop · Hypothesis Test
14
Data presented as median (range) for tmax and tlast, and geometric mean (geometric CV%) for Cmax and AUClast.analyze_data
Open slide detailBeat · SolutionLoop · Hypothesis Test
15
summarize
Open slide detailBeat · Action